Madrigal Pharmaceuticals ($MDGL) Insider Trading & Smart Money Activity
Madrigal Pharmaceuticals, Inc. ($MDGL) has 6 insider trades, 2 13F position changes and 1 analyst rating on file. Insiders filed 6 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 1
MDGL insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 2 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MDGL insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Citigroup | Reiterates to Buy | PT $725 | — | |||||||
| Insider | Rebecca Taub | Buy (Grant or award) | 454 sh | — | |||||||
| Insider | Richard Levy | Buy (Grant or award) | 766 sh | — | |||||||
| Insider | Jacqualyn Fouse | Buy (Grant or award) | 766 sh | — | |||||||
| Insider | James Daly | Buy (Grant or award) | 766 sh | — | |||||||
| Insider | Daniel Brennan | Buy (Grant or award) | 404 sh | — | |||||||
| Insider | Baker Bros. Advisors LP | Buy (Grant or award) | 1.82K sh | — | |||||||
| 13F | Alkeon Capital Management | Reduced | -160K sh | $37.94M | — | ||||||
| 13F | Alkeon Capital Management | Reduced | -160K sh | $42.96M | — |
1W / 1M / 6M = how MDGL moved from the trade or filing date.
Insider trading in MDGL: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Rebecca Taub | 1 | — | Jun 17, 2026 | ||
| Richard Levy | 1 | — | Jun 17, 2026 | ||
| Jacqualyn Fouse | 1 | — | Jun 17, 2026 | ||
| James Daly | 1 | — | Jun 17, 2026 | ||
| Daniel Brennan | 1 | — | Jun 17, 2026 | ||
| Baker Bros. Advisors LP | 1 | — | Jun 17, 2026 |
Institutions moving MDGL (13F)
Analyst ratings on MDGL
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Citigroup | Reiterates | Buy | $725 | — |
Frequently asked questions
What is the latest insider trade in MDGL?
Rebecca Taub filed a buy (grant or award) of 454 sh on Jun 17, 2026.
Which institutions changed their MDGL positions?
Recent 13F filers moving the stock include Alkeon Capital Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.